Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Use of an enzyme-linked immunoassay for Clostridium difficile serogrouping.

Delmée M, Depitre C, Corthier G, Ahoyo A, Avesani V.

J Clin Microbiol. 1993 Sep;31(9):2526-8.

2.

Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.

Depitre C, Delmee M, Avesani V, L'Haridon R, Roels A, Popoff M, Corthier G.

J Med Microbiol. 1993 Jun;38(6):434-41.

PMID:
8510136
3.

Heterogeneity of Clostridium difficile isolates from infants.

Collignon A, Ticchi L, Depitre C, Gaudelus J, Delmée M, Corthier G.

Eur J Pediatr. 1993 Apr;152(4):319-22.

PMID:
8482281
5.

Production of monoclonal antibodies against Clostridium difficile cytotoxin using immunosorbent binding bioassay procedure.

Depitre C, L'Haridon RM, Lyerly DM, Barroso LA, Wilkins TD, Andremont A, Corthier G.

Toxicon. 1993 Feb;31(2):181-6.

PMID:
8456445
6.

Detection of Clostridium difficile toxins in stools. Comparison between a new enzyme immunoassay for toxin A and other routine tests.

Depitre C, Avesani V, Delmée M, Corthier G.

Gastroenterol Clin Biol. 1993;17(4):283-6.

PMID:
8339887
7.

Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.

Lyerly DM, Barroso LA, Wilkins TD, Depitre C, Corthier G.

Infect Immun. 1992 Nov;60(11):4633-9.

8.

Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo.

Chachaty E, Depitre C, Mario N, Bourneix C, Saulnier P, Corthier G, Andremont A.

Antimicrob Agents Chemother. 1992 Sep;36(9):2009-13.

9.

Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo.

Barc MC, Depitre C, Corthier G, Collignon A, Su WJ, Bourlioux P.

Antimicrob Agents Chemother. 1992 Jun;36(6):1332-5.

Supplemental Content

Loading ...
Support Center